- Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutatuion positive melanoma(BRIM-3): extended follow up of phase 3 randimised open label study2014 | Publication without faculty affiliation
- Pokračování v léčbě vemurafenibem i po progresi onemocnění2016 | Publication without faculty affiliation
- Dlouhodobé přežívání pacientky s metastazujícím melanomem při monoterapii vemurafenibem2016 | First Faculty of Medicine
- Long-term survival on vemurafenib monotherapy2017 | Publication without faculty affiliation
- Controversial impact of mutational analysis on thyroid fine-needle aspiration biopsies - pilot Study2018 | Faculty of Medicine in Hradec Králové
- Dabrafenib in the treatment of metastatic melanoma2014 | Publication without faculty affiliation
- Metastatic melanoma - when and how it should by treated2016 | Publication without faculty affiliation
- The Year 2011 is the Year of Melanoma: Melanoma Forum, Frankfurt, 19. May 20112011 | Faculty of Medicine in Hradec Králové
- Current view on the treatment of colorectal cancer2021 | Publication without faculty affiliation
